LSI vs RGEN
LSI (LSI) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
LSI does not have a complete income-statement cache yet.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the LSI and RGEN stock pages for the full models.
Not investment advice.